Patent details

EP3540071 Title: QUANTITATION OF GLYCAN MOIETY IN RECOMBINANT GLYCOPROTEINS

Basic Information

Publication number:
EP3540071
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP191555937
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
QUANTITATION OF GLYCAN MOIETY IN RECOMBINANT GLYCOPROTEINS
French Title of Invention:
QUANTIFICATION DE LA FRACTION GLYCANE DANS DES GLYCOPROTÉINES RECOMBINANTES
German Title of Invention:
QUANTIFIZIERUNG EINES GLYCANTEILS IN REKOMBINANTEN GLYKOPROTEINEN
SPC Number:

Dates

Filing date:
19/11/2015
Grant date:
06/09/2023
EP Publication Date:
18/09/2019
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
06/09/2023
EP B1 Publication Date:
06/09/2023
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
19/11/2023
Expiration date:
19/11/2035
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
30/08/2023
 
 

Name:
Amgen Inc.
Address:
One Amgen Center Drive, Thousand Oaks, California 91320-1799, United States (US)

Inventor

Name:
CHEMMALIL, Letha
Address:
United States (US)

Priority

Priority Number:
201462082014 P
Priority Date:
19/11/2014
Priority Country:
United States (US)

Classification

IPC classification:
C12Q 1/34; G01N 30/88; G01N 33/66; G01N 33/68; G01N 30/74;

Publication

European Patent Bulletin

Issue number:
202336
Publication date:
06/09/2023
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages